Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael W Pride

Showing results (11-20 of 41) with videos related to

Pageof 5
Sort By:
The Pediatric Infectious Disease Journal|October 30, 2012
Antibody responses to routine pediatric vaccines administered with 13-valent pneumococcal conjugate vaccineKristina A Bryant, Alejandra Gurtman, Douglas Girgenti, et al.
Vaccine|November 9, 2004
Interleukin-12 redirects murine immune responses to soluble or aluminum phosphate adsorbed HSV-2 glycoprotein D towards Th1 and CD4+ CTL responsesDavid Cooper, Michael W Pride, Min Guo, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 28, 2020
Safety, Tolerability, and Immunogenicity of a 20-Valent Pneumococcal Conjugate Vaccine (PCV20) in Adults 60 to 64 Years of AgeDonald Hurley, Carl Griffin, Mariano Young, et al.
Open Forum Infectious Diseases|May 25, 2026
Randomized Phase 3 Comparison of a 2-Dose and 3-Dose Regimen of a Detoxified Toxin A/B <i>Clostridioides difficile</i> Vaccine in Adults 50 Years and OlderGretchen Crook, Erik Lamberth, Stephen P Lockhart, et al.
Anaerobe|July 23, 2021
Development and clinical validation of an automated cell cytotoxicity neutralization assay for detecting Clostridioides difficile toxins in clinically relevant stools samplesArik Elfassy, Warren V Kalina, Roger French, et al.
Msphere|August 10, 2018
Evaluation of a Validated Luminex-Based Multiplex Immunoassay for Measuring Immunoglobulin G Antibodies in Serum to Pneumococcal Capsular PolysaccharidesCharles Y Tan, Fred W Immermann, Shite Sebastian, et al.
Diabetology & Metabolic Syndrome|October 14, 2017
Neutrophil killing of <i>Staphylococcus aureus</i> in diabetes, obesity and metabolic syndrome: a prospective cellular surveillance studyIngrid Lea Scully, Lisa Kristin McNeil, Sudam Pathirana, et al.
Vaccine|November 17, 2023
A phase 3 study evaluating the lot consistency, immunogenicity, safety, and tolerability of a Clostridioides difficile vaccine in healthy adults 65 to 85 years of ageShane Christensen, Salim Bouguermouh, Kumar Ilangovan, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 1, 2023
Identification of a Novel Keto Sugar Component in Streptococcus pneumoniae Serotype 12F Capsular Polysaccharide and Impact on Vaccine ImmunogenicityKelly Sackett, Paul Brown, Kaushik Dutta, et al.
Vaccine|July 9, 2022
Streptococcus pneumoniae serotype 15B polysaccharide conjugate elicits a cross-functional immune response against serotype 15C but not 15ALi Hao, Michelle M Kuttel, Neil Ravenscroft, et al.
Pageof 5

Showing results (11-20 of 41) with videos related to

Sort By:
Pageof 5
The Pediatric Infectious Disease Journal|October 30, 2012
Antibody responses to routine pediatric vaccines administered with 13-valent pneumococcal conjugate vaccineKristina A Bryant, Alejandra Gurtman, Douglas Girgenti, et al.
Vaccine|November 9, 2004
Interleukin-12 redirects murine immune responses to soluble or aluminum phosphate adsorbed HSV-2 glycoprotein D towards Th1 and CD4+ CTL responsesDavid Cooper, Michael W Pride, Min Guo, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 28, 2020
Safety, Tolerability, and Immunogenicity of a 20-Valent Pneumococcal Conjugate Vaccine (PCV20) in Adults 60 to 64 Years of AgeDonald Hurley, Carl Griffin, Mariano Young, et al.
Open Forum Infectious Diseases|May 25, 2026
Randomized Phase 3 Comparison of a 2-Dose and 3-Dose Regimen of a Detoxified Toxin A/B <i>Clostridioides difficile</i> Vaccine in Adults 50 Years and OlderGretchen Crook, Erik Lamberth, Stephen P Lockhart, et al.
Anaerobe|July 23, 2021
Development and clinical validation of an automated cell cytotoxicity neutralization assay for detecting Clostridioides difficile toxins in clinically relevant stools samplesArik Elfassy, Warren V Kalina, Roger French, et al.
Msphere|August 10, 2018
Evaluation of a Validated Luminex-Based Multiplex Immunoassay for Measuring Immunoglobulin G Antibodies in Serum to Pneumococcal Capsular PolysaccharidesCharles Y Tan, Fred W Immermann, Shite Sebastian, et al.
Diabetology & Metabolic Syndrome|October 14, 2017
Neutrophil killing of <i>Staphylococcus aureus</i> in diabetes, obesity and metabolic syndrome: a prospective cellular surveillance studyIngrid Lea Scully, Lisa Kristin McNeil, Sudam Pathirana, et al.
Vaccine|November 17, 2023
A phase 3 study evaluating the lot consistency, immunogenicity, safety, and tolerability of a Clostridioides difficile vaccine in healthy adults 65 to 85 years of ageShane Christensen, Salim Bouguermouh, Kumar Ilangovan, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 1, 2023
Identification of a Novel Keto Sugar Component in Streptococcus pneumoniae Serotype 12F Capsular Polysaccharide and Impact on Vaccine ImmunogenicityKelly Sackett, Paul Brown, Kaushik Dutta, et al.
Vaccine|July 9, 2022
Streptococcus pneumoniae serotype 15B polysaccharide conjugate elicits a cross-functional immune response against serotype 15C but not 15ALi Hao, Michelle M Kuttel, Neil Ravenscroft, et al.
Pageof 5